Infographic: Causes of ischemic stroke

Learn more about stroke care.Other health tip infographics: mayohealthhighlights.startribune.com
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news

Related Links:

Authors: Alsadat N, Hyun K, D'Souza M, Chew D, Weaver J, Juergens C, Kritharides L, Hammett C, Brieger D Abstract BACKGROUND: Approximately 50% of patients undergoing primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) have multivessel coronary disease (MVD). Evidence on the best PCI approach for these patients is conflicting. The aim of this study is to examine Australian data from the CONCORDANCE registry to describe the practice and outcomes of patients receiving multivessel vs culprit-only PCI. METHODS: Two cohorts were constructed from MVD-STEMI patients undergoi...
Source: The Journal of Invasive Cardiology - Category: Cardiology Tags: J Invasive Cardiol Source Type: research
CONCLUSIONS: The MCAO animal model was successfully established on SD rats using the microsurgery to assess arterial embolization of intracranial tissue injury. PMID: 31306147 [PubMed - as supplied by publisher]
Source: Journal of X-Ray Science and Technology - Category: Radiology Tags: J Xray Sci Technol Source Type: research
Thrombosis is the main pathogenesis of acute ischemic stroke (AIS). The main treatments for stroke either have limited efficacy or increase the risk of bleeding. ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) is a metal protease that can effectively break down VWF (Von Willebrand Factor, VWF), the key factor in thrombus formation. Previous studies have proven that the abnormality of its activity is associated with many diseases. In recent years, it has been found that ADAMTS13 is closely related to stroke. We focus on the relationship between ADAMTS13 and acute ischemic stroke,...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
AbstractIschemic stroke is a disease that affects people’s health and quality of life. Cystatin C has been found as a new biomarker of cardiovascular disease. We performed this meta-analysis to assess the relationship between cystatin C and the risk of ischemic stroke. The studies on looking at the association between cystatin C and ischemic stroke were identified from inception to November 18, 2018. We performed a random-effects meta-analysis using mean difference. Nine studies with a total of 3773 ischemic stroke patients were included into the meta-analysis. Our results showed that patients with ischemic stroke ha...
Source: Journal of Molecular Neuroscience - Category: Neuroscience Source Type: research
Authors: Tao D, Liu F, Sun X, Qu H, Zhao S, Zhou Z, Xiao T, Zhao C, Zhao M Abstract Stroke often leads to neuronal injury and neurological functional deficits. Whilst spontaneous neurogenesis and axon regeneration are induced by ischemic stroke, effective pharmacological treatments are also essential for the improvement of neuroplasticity and functional recovery after stroke. However, no pharmacological therapy has been demonstrated to be able to effectively improve the functional recovery after stroke. Bumetanide is a specific Na +-K +-Cl- co-transporter inhibitor which can maintain chloride homeostasis ...
Source: Restorative Neurology and Neuroscience - Category: Neurology Tags: Restor Neurol Neurosci Source Type: research
Initiating stroke treatment just 15 minutes faster can save lives and prevent disability, according to a new UCLA-led study, published today inJAMA. The research also determined that busier hospitals — those that treat more than 450 people for stroke each year — have better outcomes than those that treat fewer than 400 stroke patients per year.Researchers at the  David Geffen School of Medicine at UCLA and five other institutions in the U.S. and Canada, examined data for 6,756 people who experienced ischemic strokes. The patients ’ median age was 71, and 51.2% were women.The researchers looked at str...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
Conditions:   Visual Fields Hemianopsia;   Stroke, Ischemic;   Stroke Hemorrhagic Interventions:   Device: High frequency repetitive transcranial magnetic stimulation (rTMS);   Device: Sham stimulation Sponsor:   Ain Shams University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Acute Ischemic Stroke;   Abnormal Glucose Metabolism Intervention:   Drug: Urinary Kallidinogenase Sponsor:   The Second Hospital of Hebei Medical University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Visual Fields Hemianopsia;   Stroke, Ischemic;   Stroke Hemorrhagic Interventions:   Device: High frequency repetitive transcranial magnetic stimulation (rTMS);   Device: Sham stimulation Sponsor:   Ain Shams University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Acute Ischemic Stroke;   Abnormal Glucose Metabolism Intervention:   Drug: Urinary Kallidinogenase Sponsor:   The Second Hospital of Hebei Medical University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Databases & Libraries | Ischemic Stroke | Learning | Stroke | Universities & Medical Training